Naveen Shridhar
Novo Nordisk (India)(IN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Hemophilia Treatment and Research, Cell Adhesion Molecules Research
Most-Cited Works
- → The experimental power of FR900359 to study Gq-regulated biological processes(2015)360 cited
- → CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours(2023)272 cited
- → Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy(2017)270 cited
- → Direct targeting of Gα q and Gα 11 oncoproteins in cancer cells(2019)106 cited
- → Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer(2017)23 cited
- → Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells(2015)16 cited
- → Tumor cell intrinsic Toll‐like receptor 4 signaling promotes melanoma progression and metastatic dissemination(2021)10 cited
- → The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy(2021)9 cited
- → Driving improvement of diagnosis and awareness of heavy menstrual bleeding in women among physicians(2024)6 cited
- → Driving Change: Improving Diagnosis and Awareness of Heavy Menstrual Bleeding and Bleeding Disorders in Women and Girls Among Healthcare Providers(2022)2 cited